444 related articles for article (PubMed ID: 26104333)
1. Virus-neutralizing antibody response of mice to consecutive infection with human and avian influenza A viruses.
Janulíková J; Stropkovská A; Bobišová Z; Košík I; Mucha V; Kostolanský F; Varečková E
Acta Virol; 2015 Jun; 59(2):166-73. PubMed ID: 26104333
[TBL] [Abstract][Full Text] [Related]
2. Immune response of mice to non-adapted avian influenza A virus.
Stropkovská A; Mikušková T; Bobišová Z; Košík I; Mucha V; Kostolanský F; Varečková E
Acta Virol; 2015 Dec; 59(4):350-9. PubMed ID: 26666183
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
4. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
[TBL] [Abstract][Full Text] [Related]
5. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
[TBL] [Abstract][Full Text] [Related]
6. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
8. Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2).
Li TW; Cheng SF; Tseng YT; Yang YC; Liu WC; Wang SC; Chou MJ; Lin YJ; Wang Y; Hsiao PW; Wu SC; Chang DK
Arch Virol; 2016 Jan; 161(1):19-31. PubMed ID: 26446888
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive Antibodies against avian influenza virus A (H5N1).
Pichyangkul S; Jongkaewwattana A; Thitithanyanont A; Ekchariyawat P; Wiboon-ut S; Limsalakpetch A; Yongvanitchit K; Kum-Arb U; Mahanonda R; Utaisincharoen P; Sirisinha S; Mason CJ; Fukuda MM
Emerg Infect Dis; 2009 Sep; 15(9):1537-9. PubMed ID: 19788839
[No Abstract] [Full Text] [Related]
10. Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus.
Segovia KM; França MS; Leyson CL; Kapczynski DR; Chrzastek K; Bahnson CS; Stallknecht DE
PLoS One; 2018; 13(4):e0196394. PubMed ID: 29698449
[TBL] [Abstract][Full Text] [Related]
11. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
12. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses.
Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW
Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980
[TBL] [Abstract][Full Text] [Related]
13. Role of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.
Turnbull ML; Wise HM; Nicol MQ; Smith N; Dunfee RL; Beard PM; Jagger BW; Ligertwood Y; Hardisty GR; Xiao H; Benton DJ; Coburn AM; Paulo JA; Gygi SP; McCauley JW; Taubenberger JK; Lycett SJ; Weekes MP; Dutia BM; Digard P
J Virol; 2016 Oct; 90(20):9263-84. PubMed ID: 27489273
[TBL] [Abstract][Full Text] [Related]
14. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
Hu H; Voss J; Zhang G; Buchy P; Zuo T; Wang L; Wang F; Zhou F; Wang G; Tsai C; Calder L; Gamblin SJ; Zhang L; Deubel V; Zhou B; Skehel JJ; Zhou P
J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297
[TBL] [Abstract][Full Text] [Related]
15. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
[TBL] [Abstract][Full Text] [Related]
16. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
Ramírez-Salinas GL; García-Machorro J; Rojas-Hernández S; Campos-Rodríguez R; de Oca AC; Gomez MM; Luciano R; Zimic M; Correa-Basurto J
Arch Virol; 2020 Apr; 165(4):891-911. PubMed ID: 32060794
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
[TBL] [Abstract][Full Text] [Related]
19. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD
Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
